WOMEN'S REPRODUCTIVE HEALTH RESEARCH CAREER DEVELOPMENT CENTERS-WRHR

RELEASE DATE:  April 4, 2003 

RFA:  HD-03-020

National Institute of Child Health and Human Development (NICHD)
 (http://www.nichd.nih.gov/)
Office of Research on Women's Health (ORWH)
 (http://www4.od.nih.gov/orwh/)

CATALOG OF FEDERAL DOMESTIC ASSISTANCE NUMBER:  93.864   

LETTER OF INTENT RECEIPT DATE:  June 30, 2003

APPLICATION RECEIPT DATE:  July 29, 2003

THIS RFA CONTAINS THE FOLLOWING INFORMATION

o Purpose of this RFA
o Research Objectives
o Mechanism of Support
o Funds Available
o Eligible Institutions
o Individuals Eligible to become Principal Investigators
o Special Requirements
o Where to Send Inquiries
o Letter of Intent
o Submitting an Application
o Peer Review Process
o Review Criteria
o Receipt and Review Schedule
o Award Criteria
o Required Federal Citations

PURPOSE OF THIS RFA

The National Institute of Child Health and Human Development (NICHD) and the 
NIH Office of Research on Women's Health (ORWH) invite institutional career 
award applications for Women's Reproductive Health Research Career 
Development Centers, hereafter termed "Centers."  These awards will support 
research career development of obstetrician-gynecologists, to be known as 
Women's Reproductive Health Research (WRHR) Scholars, who have recently 
completed postgraduate clinical training, and who are commencing basic, 
translational, and/or clinical research relevant to women's health.  The goal 
of this initiative is to promote the performance of research and transfer of 
findings that will benefit the health of women.  The Centers will accomplish 
this by bridging clinical training with research independence, increasing the 
number and skills of obstetrician-gynecologist investigators at awardee 
institutions through a mentored research experience leading to an independent 
scientific career addressing women's reproductive health concerns.  This 
program will result in a well-qualified cadre of academic obstetrician-
gynecologist investigators who will help strengthen the research capacity in 
health professional institutions and meet the need for highly skilled 
scientists with a clinical background who can address the increasing research 
opportunities in women's health.

RESEARCH OBJECTIVES

Background

This initiative addresses a continued need for expanded support for bridging 
clinical training with an independent career in research addressing women's 
health concerns.  Awards resulting from this RFA would meet this specified 
need by providing departments of Obstetrics and Gynecology, both developing 
and established, an opportunity to build a national capacity for junior 
investigators in women's health research.  One objective of this initiative 
is to promote the performance of research and transfer of findings that are 
relevant to women's reproductive health.  Investigators with established 
research programs covering a broad range of basic and applied biomedical and 
biobehavioral science in the Obstetrics-Gynecology and collaborating 
departments will form an intellectual and technical research base for 
mentoring WRHR Scholars.  Although mentors from collaborating departments may 
provide needed expertise and resources, the emphasis of the WRHR Scholars' 
scientific projects should be on research ultimately relevant to obstetrics-
gynecology and/or its subspecialties. 

The Women's Reproductive Health Research Career Development Centers Program 
was initiated by NICHD in 1998 in response to concerns about the need for 
greater numbers of physician scientists in women's health research.  This 
initiative continues and expands the scientific objectives represented in 
RFA HD-98-004 and RFA HD-99-001 and that were responsive to the 1992 Institute 
of Medicine Report, "Strengthening Research in Academic OB/Gyn Departments," 
the 1997 NICHD Extramural Program 5-Year Plan Report:  "A Research Agenda for 
the Reproductive Sciences Branch," and report language in the Fiscal Year 1998 
House Appropriations Report (No. 105-205; July 25, 1997).  

This RFA represents an expansion of ongoing research efforts to increase the 
numbers of physician scientists and support the research career development 
of junior faculty.  Moreover, this initiative reflects the NICHD research 
agenda for expanding the scope of women's reproductive health research. 

Research Scope

The research scope encompasses all areas of obstetrics and gynecology and its 
subspecialties:  maternal-fetal medicine, gynecologic oncology, and 
reproductive endocrinology and infertility, as well as relevant fields such 
as urogynecology, adolescent gynecology, and the reproductive health of women 
with disabilities.  Projects may be basic, translational, and/or clinical 
research, but must be within the biomedical and biobehavioral purview of NIH.  
Research with a primary focus on health care delivery, health services, or 
health policy is outside the scope of this RFA.  Research focused on somatic 
health, for example, breast, cardiovascular, or musculoskeletal systems, 
should similarly not be proposed.

MECHANISM OF SUPPORT

This RFA will use the NIH Mentored Research Scientist Development Program 
(K12) award mechanism.  Planning, direction, and execution of each component 
of the research and career development program will be the responsibility of 
the Principal Investigator and WRHR Scholar with the guidance of his or her 
mentor.  This RFA is a one-time solicitation.  Future unsolicited, competing-
continuation applications based on this project will not be accepted unless 
the RFA is reissued.  As an applicant you will be solely responsible for 
planning, directing, and executing the proposed project.  The anticipated 
award date is April 01, 2004.  

FUNDS AVAILABLE

The NICHD and ORWH intend to commit approximately $5.6 million total costs 
[Direct plus Facilities and Administrative (F and A) costs] in FY 2004 to 
support up to 14 new and/or competing continuation grants in response to this 
RFA.  An applicant may request a project period of up to five years and a 
budget for direct costs of up to $400,000 per year.  Because the nature and 
scope of the proposed research will vary from application to application, it 
is anticipated that the size and duration of each award will also vary. 
Although the financial plans of the NICHD and ORWH provide support for this 
program, awards pursuant to this RFA are contingent upon the availability of 
funds and the receipt of a sufficient number of meritorious applications.

ELIGIBLE INSTITUTIONS

You may submit an application if your institution has any of the following 
characteristics: 

o For-profit or non-profit organizations 
o Public or private institutions, such as universities, colleges, hospitals, 
  medical schools and other institutions of higher education 
o Units of State and local governments 
o Eligible agencies of the Federal government  
o Domestic institutions 

Eligible institutions are those that will not have a current WRHR Center at 
the time of the award.  Foreign institutions are not eligible for this 
institutional career award.

Applications may be submitted on behalf of departments of Obstetrics and 
Gynecology.  An eligible institution will have a Department of Obstetrics and 
Gynecology (here understood to include a department providing obstetrical 
and/or gynecologic care as its primary function, regardless of title) that 
has as a primary teaching site either a hospital for women or an obstetrics-
gynecology program with an identifiable organizational structure within a 
larger medical institution in the United States of America.  Applicant 
institutions must have the clinical specialties and subspecialties and the 
clinical and research facilities sufficient to meet the purposes of the 
Center program, namely, to bridge clinical training with a career in basic, 
translational and/or clinical research relevant to women's reproductive 
health.  

Those institutions with a current Building Interdisciplinary Research Careers 
in Women's Health (BIRCWH) Program, with a focus on women's reproductive 
health and/or located in a Department of Obstetrics and Gynecology or a 
department providing obstetrical and/or gynecologic care as its primary 
function must demonstrate how the addition of a WRHR Center will provide 
career development training that is separate and distinct from that offered 
by the BIRCWH Program, including avoidance of overlap in terms of research 
topics and personnel.

INDIVIDUALS ELIGIBLE TO BECOME PRINCIPAL INVESTIGATORS

Any individual with the skills, knowledge, and resources necessary to carry 
out the proposed research is invited to work with their institution to 
develop an application for support.  Individuals from underrepresented racial 
and ethnic groups as well as individuals with disabilities are always 
encouraged to apply for NIH programs.   

The Principal Investigator of a Center must be the Chair of the Department of 
Obstetrics and Gynecology, or equivalent.  He/she should possess the 
scientific expertise, leadership, and administrative capabilities required to 
coordinate and supervise a multidisciplinary research and development program 
of this scope.  

SPECIAL REQUIREMENTS

A.  WRHR Scholars:  The Scholar position is a junior faculty appointment, not 
a fellowship.  At the time of the award, candidates for support as WRHR 
Scholars must:  (1) be a physician holding the M.D. or D.O. degree; (2) have 
completed postgraduate residency training in obstetrics-gynecology or 
postdoctoral fellowship training in its subspecialties, if they have chosen 
to subspecialize; (3) identify an approved mentor with extensive research 
experience; (4) be able to spend at least of 75 percent of full-time 
professional effort conducting research and research career development; (5) 
not be or have been a Principal Investigator on an R01, R29 or subproject of 
a Program Project (P01), Center (P50, P60, U54) grant, mentored career 
development (K-series) grants, or other equivalent research grant awards; and 
(6) be a U.S. citizen or noncitizen national, or must have been lawfully 
admitted for permanent residence and possess an Alien Registration Receipt 
Card (I-151 or I-155) or some other verification of legal admission as a 
permanent citizen.  Individuals on temporary or student visas are not 
eligible.  

Completion of subspecialty training is not required of candidates practicing 
general obstetrics and gynecology.  However, those who choose to 
subspecialize must have completed their fellowship.  In order to accommodate 
the needs of those interested in participating in this program who may have 
had a career hiatus because of family responsibilities, uniformed service, 
etc., there is no limit on time elapsed since completion of training.  
However, Scholars cannot have more than six years of research training 
experience beyond their last doctoral degree.  

Support is in the form of a minimum of two consecutive 12-month appointments, 
renewable in annual increments for up to five years total, and is contingent 
upon satisfactory progress as reported to the Advisory Committee and to NICHD 
in the annual progress report of the Center.  WRHR Scholars may not accept or 
hold any other PHS award that duplicates the provisions of this career award.  
Centers are encouraged to recruit members of underrepresented minorities, 
women, and candidates with disabilities.  During the period of this award, 
WRHR Scholars are encouraged to apply for, and may accept and hold, 
independent research grant support with the consent of NICHD Program Staff.

New Scholar appointments to the Center are made after approval by NICHD 
Program Staff.  New Scholar appointments will have start dates of July 1 and 
January 1.  

B.  Center Composition:  Applicants must describe or propose a 
multidisciplinary career development program that will maximize the use of 
relevant research and educational resources to foster education, training, 
mentoring, and professional development of scholars, including women and 
minorities, in biomedical careers.  The Center must have a strong research 
base, comprising the research investigations of established scientists who 
will provide expertise, resources, and mentoring to the WRHR Scholars.  The 
research base must be broad and relevant to current areas of research 
interest and need in women's reproductive health.  The environment should be 
one that will stimulate and increase the interactions between basic 
scientists and clinical investigators likely to benefit from mentored 
research career development.  Of major importance, the Center must have a 
scientifically sound and equitable procedure for recruiting and selecting 
WRHR Scholars and projects to be supported.  There must be documented 
evidence of an institutional commitment to support the Center's human and 
tangible resources and its goal of developing and retaining productive, 
independent investigators in areas of women's reproductive health concerns.  

There should be a plan for ongoing evaluation of the Center in terms of 
recruitment and retention goals, including for women and minorities, 
completion success, overall outcome, the curriculum, and program staff.  For 
purposes of evaluating the impact of research career development programs, 
awardees must agree to provide NICHD with information on career outcomes for 
those appointed to the program.  The Principal Investigator will supply this 
information at least annually.  There should be a plan for periodic research 
meetings and networking for all Scholars and mentors.  The NICHD will convene 
an annual meeting for Scholars and relevant program personnel at the NIH.

C.  Principal Investigator:  The Principal Investigator of a Center must be 
the Chair of the Department of Obstetrics and Gynecology, or equivalent.  
He/she should possess the scientific expertise, leadership, and 
administrative capabilities required to coordinate and supervise a 
multidisciplinary research and development program of this scope.    

As an option, the application may request a co-investigator to serve as the 
Program Director, with responsibility for some or all of the day-to-day 
operations of the Center.  The Program Director should be an established 
investigator and have experience and qualifications complementing those of 
the Principal Investigator.  The Program Director should possess the 
scientific expertise, leadership, and administrative capabilities required to 
coordinate and supervise a program for developing junior investigators.  The 
Program Director should have a record of accomplishment for mentoring 
successful investigators.

D.  Career Development Program:  The K12 award provides five years of funding 
for the Center.  The Center will support WRHR Scholars for periods of two to 
five years consisting of consecutive 12-month appointments.  The program may 
be divided into two distinct phases, if appropriate:  (1) the first one to 
two year basic and/or clinical science-training component, followed by, (2) 
an intensive research experience under the general guidance of a qualified 
mentor.  At least 75 percent of the WRHR Scholar's full-time professional 
effort must be devoted to the K12 program per se.  The remainder of the 
recipient WRHR Scholar's time may be devoted to developing other clinical or 
academic pursuits consonant with the objectives of the award.  The 75 percent 
minimum effort in this program is intended to be primarily devoted to 
research; however, Scholars may, as needed, receive formal didactic 
coursework to support their career development, which may include, for 
example, biostatistics, epidemiology, health economics, clinical evaluation 
sciences, and clinical trials.  

E.  Advisory Committee:  The Advisory Committee will be a group of scientists 
from the sponsoring department, and other departments or institutions as 
appropriate, with interests relevant to the Center's research programs.  It 
may include mentors.  The two major functions of the committee are to 
evaluate:  (1) applications from WRHR Scholar candidates, and (2) the overall 
conduct of the Center.  Specifically, the committee makes recommendations to 
the Principal Investigator as to WRHR Scholar appointments, evaluates ongoing 
research activities annually (including the interaction and integrated nature 
of the Scholars' research experience), makes recommendations regarding their 
continuation, and makes recommendations to the Principal Investigator 
regarding priorities for use of the Resource Laboratory, if applicable.  The 
committee may use institutional or outside consultants if needed.  Plans to 
include members or consultants from outside institutions may be described, 
but such individuals should not be named.  The committee is a formal part of 
the structure of the Center.  It should meet regularly and keep written 
minutes, which will be reviewed as part of a competing or noncompeting 
application.  In addition, an annual evaluation by the Advisory Committee is 
recommended.

F.  Institutional Environment:  Applicant institutions should show commitment 
to the Center's goals, and provide assurances that the institution intends 
the Center and the supported WRHR Scholars to be an integral part of its 
research endeavor.  Research facilities and training opportunities will be a 
critical part of the environment.  Applicant institutions should provide a 
guarantee of 75 percent protected time for the WRHR Scholars for research.  
Applicant institutions should demonstrate commitment to recruitment and 
retention of racial and ethnic minorities and individuals with disabilities 
by collaborating with less research intensive and minority institutions.

G.  Mentors:  Each WRHR Scholar appointed under the K12 award must have a 
primary sponsor who is recognized as an independent investigator and who is 
actively involved in basic, translational, and/or clinical research relevant 
to this initiative, and who has a successful record of providing research 
training of a type expected in this Center.  An assigned mentor will provide 
guidance for the development of each WRHR Scholar assigned to the program.  
The mentor must be committed to continue this involvement throughout the WRHR 
Scholar's total period of development under the award.  Mentors not included 
in this application must be approved by NICHD Program Staff before being 
assigned a Scholar.

H.  Resource Laboratory:  The laboratory resources of the Center comprise the 
research laboratories of the established investigators serving as mentors, as 
well as a shared resource laboratory to be utilized by the mentors and the 
WRHR Scholars whose activities they will supervise.  With strong 
justification, a shared Resource Laboratory may be requested as part of the 
Center, within the total budget.  Such a resource would provide skilled 
technical services to complement and extend the capabilities of the mentors 
to promote the career development of the WRHR Scholars.  The shared Resource 
Laboratory might include scientific services such as, but not limited to, 
assays, molecular biology or biostatistics.  Requests for this Resource 
Laboratory must be justified in terms of cost-effective enhancement of the 
research resources that will serve at least three WRHR Scholars' projects.  
The laboratories of the mentors are not supported directly by the K12 grant.  
The Resource Laboratory, if any, must be a new entity, not an extension or 
enhancement of an existing facility.  The award may support professional 
direction of the Resource Laboratory, up to 50 percent effort, as well as 
technical assistance, supplies, equipment, and appropriate costs of 
operation.  Institutional commitment to the shared Resource Laboratory must 
be demonstrated, and may take the form of providing or renovating space, 
purchase of required equipment, and/or support of personnel.  The Principal 
Investigator, Program Director, and Resource Laboratory Director are 
responsible for efficient and equitable utilization of the Resource 
Laboratory based on recommendations from the Advisory Committee.

I.  Allowable Costs:

1.  The Center structure may have these elements:

a) Administration costs:  Salary and fringe benefits for the Program 
Director, if any, up to 10 percent effort, as well as a part-time secretary, 
may be requested.  No compensation may be requested for the Principal 
Investigator.  Travel to an annual NIH Directors' meeting for the Principal 
Investigator and the Program Director, as well as travel to an annual NIH 
meeting for current Scholars, must be requested.  Travel must also be 
requested for one additional training or scientific meeting per year for 
current Scholars.

b) Resource Laboratory costs:  Budgets may include salaries and fringe 
benefits for a Resource Laboratory Director (up to 50 percent), other 
technical staff, supplies, animals, and equipment purchase and maintenance.  
The budget for the Resource Laboratory must be included in the Administration 
cost.  The sum of the budgets for Administration and a Resource Laboratory 
may not exceed $100,000 total costs (Direct plus F & A costs) per year.

c) Facilities and Administrative costs:   F & A (formerly, indirect) costs 
will be reimbursed at eight percent of modified total direct costs.

2.  As part of the Scholars' costs, an application must request a minimum of 
three WRHR Scholar positions.  The NIH will provide support for each WRHR 
Scholar position of up to $100,000 total costs (Direct plus F & A) per year.  

a) Salary Support:  Scholars may be provided salary support of no more than 
$75,000 plus fringe benefits annually.  The institution may supplement the 
NIH salary contribution up to a level that is consistent with the 
institution's salary scale; however, supplementation may not be from Federal 
funds unless specifically authorized by the Federal program from which such 
funds are derived.  In no case may PHS funds be used for salary 
supplementation.  Institutional supplementation of salary must not require 
extra duties or responsibilities that would interfere with the purpose of the 
Center.  The total salary requested for each WRHR Scholar must be based on a 
full-time, 12-month staff appointment.  It must be consistent both with the 
established salary structure at the institution and with salaries actually 
provided by the institution from its own funds to other staff members of 
equivalent qualifications, rank, and responsibilities in the department 
concerned.  If full-time, 12-month salaries are not currently paid to 
comparable staff members, the salary proposed must be appropriately related 
to the existing salary structure.

b) Research Development Support:  Within each WRHR Scholar's total award, up 
to $25,000 annually is allocated for research and development support, which 
can include expenses such as (a) travel to training or scientific meetings; 
(b) tuition, fees and books; (c) supplies and equipment; and (d) technical 
support and statistical or computer services.  These career and development 
costs must be specifically documented for each individual candidate and must 
be specifically related to the candidate's research activities.  They cannot 
be pooled and used for other programs unrelated or indirectly related to the 
research activities of individual scholars.  

Grant funds may not be requested for the following:  Compensation for the 
Principal Investigator or mentors; direct support of the mentors' 
laboratories; compensation of administrative personnel normally paid from 
institutional overhead charges; administrative activities such as public 
relations, or health or educational services; travel of the Principal 
Investigator, Program Director or mentors to scientific meetings; costs of 
clinical care; and alterations and renovations.

J.  Evaluation:  In carrying out its stewardship of human resource-related 
programs, the NICHD may begin requesting information essential to an 
assessment of the effectiveness of the Centers.  Accordingly, awardee 
institutions are hereby notified that WRHR Scholars may be contacted after 
the completion of their career development experiences for periodic updates 
on various aspects of their employment history, publications, support from 
research grants or contracts, honors and awards, professional activities, and 
other information helpful in evaluating the impact of the Center.

K.  Other Income:  Fees resulting from clinical practice, professional 
consultation, or other comparable activities required by the research and 
research-related activities of this award may not be retained by the 
candidate.  Such fees must be assigned to the grantee institution for 
disposition by any of the following methods:

The funds may be expended by the grantee institution in accordance with the 
NIH policy on supplementation of career award salaries and to provide fringe 
benefits in proportion to such supplementation.  Such salary supplementation 
and fringe benefit payments must be within the established policies of the 
grantee institution.

The funds may be used for health-related research purposes.

The funds may be paid to miscellaneous receipts of the U.S. Treasury.  Checks 
should be made payable to the Department of Health and Human Services, NIH, 
and forwarded to the Director, Division of Financial Management, NIH, 
Bethesda, Maryland 20892.  Checks must identify the relevant award account 
and reason for the payment.

Center personnel supported by the K12 award may retain royalties and fees for 
activities such as scholarly writing, service on advisory groups, or 
honoraria from other institutions for lectures or seminars, provided these 
activities remain incidental and provided that the retention of such pay is 
consistent with the policies and practices of the grantee institution.

Usually, funds budgeted in an NIH-supported research or training grant for 
the salaries or fringe benefits of individuals, but freed as a result of a 
career award, may not be rebudgeted.  An institute will give consideration to 
approval for use of released funds only under unusual circumstances.  Any 
proposed retention of funds released as a result of an NIH career award must 
receive prior written approval of the institute-awarding component.

L.  Special Leave:  Candidates appointed to this program career award may 
engage in research experiences at another institution, including a foreign 
site, if directly related to the purpose of the award.  Only local, 
institutional approval is required if such leave does not exceed three 
months.  For longer periods, prior written approval of the awarding component 
is required.  To obtain prior approval, the Principal Investigator must 
submit a letter describing the plan, countersigned by the appropriate 
institutional official, to the awarding component.  A copy of a letter or 
other evidence from the performing institution where the leave is to be taken 
must be submitted to assure that satisfactory arrangements have been made.  
Support from the career award will continue during such leave. 

Leave without award support may not exceed 12 months.  Such leave requires 
the prior written approval of the PHS funding component and will be granted 
only in an unusual situation.  Support from other sources is permissible 
during the period of leave.  Such leave does not reduce the total number of 
months of program support for which an individual is eligible.  Parental 
leave will be granted consistent with the policies of the NIH and the grantee 
institution.

M.  Termination:  The Director of the NIH may discontinue an award upon 
determination that the purpose or terms of the award are not being fulfilled.  
In the event, an award is terminated, the Director of the NIH shall notify 
the grantee institution in writing of this determination, the reasons 
therefore, the effective date, and the right to appeal the decision.

N.  Changes of Program:  Awards are made to a specific institution for a 
specific Center under the guidance of a particular Principal Investigator and 
Program Director, if any.  Changes in any of these parameters require prior 
approval by NICHD Program Staff.

O.  Progress Reports:  An Annual Progress Report for the grant is required.  
This report should provide information such as any changes in the Center, a 
summary report of the evaluation of the Advisory Committee, and a description 
of the research and career progress of each Scholar. 

A final progress report, invention statement, and Financial Status Report are 
required upon termination or relinquishment of an award.

WHERE TO SEND INQUIRIES

We encourage inquiries concerning this RFA and welcome the opportunity to 
answer questions from potential applicants.  Inquiries may fall into three 
areas:  scientific/research, peer review, and financial or grants management 
issues:  

o Direct your questions about scientific/research issues to:  

Estella Parrott, M.D., M.P.H.
Center for Population Research
National Institute of Child Health and Human Development
6100 Executive Boulevard, Room 8B-01, MSC 7510
Bethesda, Maryland  20892-7510
Telephone:  (301) 496-6515
FAX:  (301) 496-0962
Email:  ep61h@nih.gov 

o Direct your questions about peer review issues to:  

Robert Stretch, Ph.D.
Director, Division of Scientific Review
National Institute of Child Health and Human Development
6100 Executive Boulevard, Room 5B01, MSC 7510
Bethesda, MD 20892-7510
Telephone:  (301) 496-1485
FAX:  (301) 402-4104
Email:  stretchr@mail.nih.gov 

o Direct your questions about financial or grants management matters to:  

Mary Ellen Colvin
Grants Management Branch
National Institute of Child Health and Human Development
6100 Executive Boulevard, 8A17, MSC 7510
Bethesda, MD  20892-7510
Telephone:  (301) 496-5482
FAX:  (301) 402-0915
Email:  mc113b@nih.gov 

LETTER OF INTENT

Prospective applicants are asked to submit a letter of intent that includes 
the following information:  

o Descriptive title of the proposed research 
o Name, address, and telephone number of the Principal Investigator 
o Names of other key personnel 
o Participating institutions 
o Number and title of this RFA 

Although a letter of intent is not required, is not binding, and does not 
enter into the review of a subsequent application, the information that it 
contains allows NICHD staff to estimate the potential review workload and 
plan the review.

The letter of intent is to be sent by the date listed at the beginning of 
this document.  The letter of intent should be sent to:  

Estella Parrott, M.D., M.P.H.
Center for Population Research
National Institute of Child Health and Human Development
6100 Executive Boulevard, Room 8B-01, MSC 7510
Bethesda, Maryland  20892-7510
Telephone:  (301) 496-6515
FAX:  (301) 496-0962
Email:  ep61h@nih.gov 

SUBMITTING AN APPLICATION

Applications must be prepared using the PHS 398 research grant application 
instructions and forms (rev. 5/2001).  The PHS 398 is available at 
http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive 
format.  For further assistance contact GrantsInfo, Telephone (301) 435-0714, 
Email:  GrantsInfo@nih.gov.   

SUPPLEMENTAL INSTRUCTIONS:  The application must use the Research Career 
Award (RCA) section of the PHS 398.  The table of contents for the RCA should 
be followed, except for those items modified under Sections I and II (below).

The abstract should summarize the actual proposal, including the candidate 
pool, research topics, goal of the program regarding career development, and 
the environment.

Section I - Basic Administrative Data:  

Include all the information requested in this RCA section.

List as Key Personnel the Principal Investigator, Program Director, if any, 
Resource Laboratory Director, if any, and mentors.  Do not list Advisory 
Committee members unless they are also mentors.  

Budget requests must be provided according to the instructions in form PHS 
398.  A composite page 4 for the entire Center budget request should be 
followed by one page 4 for the Scholars' costs and one page 4 for 
Administration and shared Resource Laboratory (if applicable) costs.  Provide 
page 5 for the composite only.  The requests for tuition and fees, books, 
travel, research development expenses, etc., must be justified and specified 
by category.  

Provide a Biographical Sketch and Other Support pages for all Key Personnel. 

Section II - Specialized Information:  

Make the following modifications in this RCA section.

(1) Begin with an overview of the proposed Center:  Summarize the immediate 
and long-term objectives of the Center.  Describe the background, purpose and 
objectives of this career development Center.  This description should 
include a discussion of the strategies to be used to ensure that the 
objectives of this RFA are met.  The description should clearly show how the 
purpose and objectives meet the broader objectives and intent of NICHD to 
suppport the development of independent ob/gyn investigators in women's 
reproductive health. 

(2) The Scholar Candidate:  Describe in general terms the pool of potential 
candidates including information about the types of prior clinical and 
research training.  Do not name prospective Scholars.  Describe the criteria 
to be used for candidate evaluation for selection as WRHR Scholars.  Describe 
plans to recruit candidates, including those from racial or ethnic groups 
that are currently underrepresented in biomedical, behavioral, or clinical 
sciences and explain how these plans will be implemented.  

(3) Statement by Sponsor:  Summarize the immediate and long-term career 
objectives of the Center, explaining how the Center will contribute to their 
attainment.  Describe the career development plans for prospective 
candidates.  Considering the Center goals and the likely goals of prospective 
candidates, describe a plan to provide the necessary research background and 
experiences, considering the expected range of prior research training in the 
applicant pool.  For example, candidates with little previous research 
experience may require a phased developmental period in which the first phase 
of support under this award may include the first year or two of didactic 
training in basic and/or clinical research sciences.  For these candidates, a 
second phase would be an intensive, supervised research experience to 
complete a longer developmental program.  More experienced candidates may 
benefit from entering immediately into a mentored research experience of at 
least two years supported by this award.  

Provide brief summaries of career development plans that the Center will 
employ.  The application should contain a description of how the career 
development plan will be tailored to the needs of the prospective candidates, 
taking into account their past experiences and competences, and should 
distinguish the plan from fellowship training.

(4) Advisory Committee:  Describe the composition of the Advisory Committee, 
identifying by name and role the internal members, and the desired expertise 
(but not the name or affiliation) of external members, if any.  Describe how 
the Advisory Committee will function in providing oversight of the 
development, implementation, and evaluation of recruitment strategies and the 
recruitment and retention of candidates.  Describe how the Advisory Committee 
will monitor and evaluate candidates and the evaluation of the overall 
effectiveness of the career development program.

(5) Environment and Institutional Commitment to Candidate:  Describe the 
research infrastructure, facilities, etc. that are available and accessible 
to this Center.  This includes the existence of funded laboratories and 
research activities that will meet and sustain the needs of the Center.  
Provide information establishing the commitment of the applicant institution, 
the Principal Investigator, and Program Director, if any, and the faculty 
mentors to providing developmental experiences that lead to independence in 
biomedical, behavioral, and/or clinical research relevant to women's 
reproductive health.  Letters from faculty mentors are not required unless 
they are collaborators from other institutions.  Include the specifics of 
institutional support.  There is no dollar requirement, but significant 
commitment will be considered a strength.  Provide a statement that Scholars 
participating in this Center will be guaranteed 75 percent protected time to 
devote to research and research career development.

Collaborations between research-intensive and less-research-intensive 
institutions, and/or minority institutions, will be considered a strength.  

(6) Research Plan:  For each faculty member proposed as a potential mentor, 
provide a paragraph describing the proposed research relevant to the goals 
expressed in this RFA, that may be the foundation of a WRHR Scholar's 
research experience in the Center.  The research experiences may include 
basic, translational, and clinical research approaches to biomedical or 
behavioral problems in women's reproductive health.  Lengthy, detailed 
protocols or plans for specific experiments should not be included.  No 
limits are specified for the number of proposed mentors; however, fewer than 
six may not provide sufficient choice of projects, while more than 25 may 
dilute the focus on women's health.  For each proposed mentor, describe the 
pertinent research experience and record of accomplishment in training junior 
investigators.  In a table, name up to five current or former students or 
fellows the faculty member has trained, with dates (month/year), where 
trained, title of project, academic level, and present position and 
institution.  Include a list of current funded research for each proposed 
mentor participating in the Center. 

The proposed Program Director, if any, should have a record of accomplishment 
for mentoring successful investigators.  Describe the scientific expertise, 
leadership, and administrative capabilities required to coordinate and 
supervise a program for developing junior investigators.  Describe the career 
development record of the Program Director, as determined by the success of 
their former students or fellows.  In a table, name up to five current or 
former students or fellows the faculty member has trained, with dates 
(month/year), where trained, title of project, academic level, and present 
position and institution.  Include a list of current funded research.  

Applicants who will be using a General Clinical Research Center (GCRC) are 
requested to include a letter with the application from either the GCRC 
Program Director or the Principal Investigator.

(7) Responsible Conduct of Research:  Applications must include plans for 
instruction in the responsible conduct of research, including the rationale, 
subject matter, appropriateness, format, frequency and duration of 
instruction, and the amount and nature of faculty participation.  No award 
will be made if an application lacks this component.  

(8) Current WRHR Centers:  For eligible WRHR Centers submitting a competing 
continuation application in response to this RFA, provide brief summaries of 
the overall career development program that has been successful in preparing 
candidates for careers as independent investigators.  Include information on 
the career outcomes of all Scholars that have entered your program over the 
course of the award.  The summary should contain information on their 
promotions, publications, support from research grants or contracts, honors 
and awards, and other relevant professional activities.  Include measures of 
success consistent with the nature and duration of the training period, and 
additional information helpful in evaluating the impact of your Center.  

(9) BIRCWH Program:  Those institutions with a current Building 
Interdisciplinary Research Careers in Women's Health (BIRCWH) Program, with a 
focus on women's reproductive health and/or located in a Department of 
Obstetrics and Gynecology or a department providing obstetrical and/or 
gynecologic care as its primary function, must provide information on how the 
addition of a WRHR Center will provide career development training that is 
separate and distinct from that offered by the BIRCWH Program, including 
avoidance of overlap in terms of research topics and personnel.

USING THE RFA LABEL:  The RFA label available in the PHS 398 (rev. 5/2001) 
application form must be affixed to the bottom of the face page of the 
application.  Type the RFA number on the label.  Failure to use this label 
could result in delayed processing of the application such that it may not 
reach the review committee in time for review.  In addition, the RFA title 
and number must be typed on line 2 of the face page of the application form 
and the YES box must be marked.  The RFA label is also available at: 
http://grants.nih.gov/grants/funding/phs398/label-bk.pdf.

SENDING AN APPLICATION TO THE NIH:  Submit a signed, typewritten original of 
the application, including the Checklist, and three signed photocopies, in 
one package to: 

Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD  20892-7710
Bethesda, MD  20817 (for express/courier service)

At the time of submission, two additional copies of the application must be 
sent to:  

Robert Stretch, Ph.D.
Director, Division of Scientific Review
National Institute of Child Health and Human Development
6100 Executive Boulevard, Room 5B01, MSC 7510
Bethesda, MD 20892-7510
Rockville, MD 20852 (for express/courier service)

APPLICATION PROCESSING:  Applications must be received by the application 
receipt date listed in the heading of this RFA.  If an application is 
received after that date, it will be returned to the applicant without 
review.

Although there is no immediate acknowledgement of the receipt of an 
application, applicants are generally notified of the review and funding 
assignment within eight weeks.
 
The Center for Scientific Review (CSR) will not accept any application in 
response to this RFA that is essentially the same as one currently pending 
initial review, unless the applicant withdraws the pending application.  
However, when a previously unfunded application, originally submitted as an 
investigator-initiated application, is to be submitted in response to an RFA, 
it is to be prepared as a NEW application.  That is the application for the 
RFA must not include an Introduction describing the changes and improvements 
made, and the text must not be marked to indicate the changes.  While the 
investigator may still benefit from the previous review, the RFA application 
is not to state explicitly how.

PEER REVIEW PROCESS

Upon receipt, applications will be reviewed for completeness by the CSR and 
responsiveness by the NICHD.  Incomplete and/or non-responsive applications 
will be returned to the applicant without further consideration.  

Applications that are complete and responsive to the RFA will be evaluated 
for scientific and technical merit by an appropriate peer review group 
convened by the NICHD in accordance with the review criteria stated below.  
As part of the initial merit review, all applications will: 

o Receive a written critique
o Undergo a process in which only those applications deemed to have the 
highest scientific merit, generally the top half of the applications under 
review, will be discussed and assigned a priority score
o Receive a second level review by the National Advisory Child Health and 
Human Development Council.

REVIEW CRITERIA

The goals of NIH-supported research are to advance our understanding of 
biological systems, improve the control of disease, and enhance health.  In 
the written comments, reviewers will be asked to discuss the following 
aspects of the application in order to judge the likelihood that the proposed 
research will have a substantial impact on the pursuit of these goals: 

Program Overall:

o  The probable impact of the award on enhancing the capacity of the grantee 
institution to develop well-qualified new obstetrician-gynecologist 
investigators, thus enhancing women's reproductive health research locally 
and nationally.  This includes the scientific and administrative expertise of 
the Principal Investigator and Program Director, if any, in preparing 
physician investigators for independent careers in basic, translational or 
clinical research.    

o  Quality of immediate and long-term career objectives of the Center. 

o  Quality of partnerships between research-intensive institutions and less-
research-intensive institutions and/or minority institutions will be 
considered a strength. 

o  For current WRHR Centers submitting a competing continuation application, 
the quality, overall impact, and effectiveness of their career development 
program in training and producing independent obstetrician-gynecologist 
investigators. 

Candidates:

o  Evidence of the availability of an adequate pool of potential WRHR Scholar 
candidates trained locally or recruited from elsewhere, who could benefit 
from receiving career development support.

o  Quality of plans to identify, recruit, and select candidates, with a 
commitment to research relevant to women's reproductive health, and the 
potential to develop as independent researchers.

o  Quality of efforts to develop a recruitment plan for women and those from 
racial and ethnic groups underrepresented in research.

Career Development Plan:

o  Likelihood that the career development plan will contribute significantly 
to the scientific development of the candidates.

o  Appropriateness of the content, the phasing, and the proposed duration of 
the career development plan for achieving scientific independence for the 
prospective candidates.

o  Consistency of the career development plan with prospective candidates' 
career goals and the multidisciplinary aims of the RFA.

o  Quality of the training in the responsible conduct of research.

Research Plan:

o  Usefulness of the research plan as a vehicle for ensuring research 
training in women's reproductive health for all Scholars as described in the 
career development plan.

Mentors:

o  Appropriateness of the faculty mentors' qualifications in the areas of 
research relevant to this RFA, including current and pending research grants.

o  Quality and extent of the mentors' proposed roles in providing guidance 
and advice to candidates.

o  Previous experience of the mentors in fostering the development of 
researchers.

Resource Laboratory, if applicable:

o  Nature and quality of the optional new Resource Laboratory:  technical 
merit, scientific justification, evidence of cost-effectiveness, procedures 
for quality control, allocation of resources among multiple users, 
qualifications of the Resource Laboratory Director and technical staff, and 
probable utility to the research projects of the WRHR Scholars.

Environment:

o  Applicant institution's commitment to the Center's scientific development 
of the WRHR Scholars, and assurances that the institution intends the Center 
and the supported WRHR Scholars to be an integral part of its research 
program.

o  Adequacy of research facilities including availability of a General 
Clinical Research Center, if applicable, and training opportunities, 
including demonstration of the research base.

o  Quality of the environment for scientific and professional development, 
including opportunities for faculty positions that emphasize research. 

o  Applicant institution's commitment to the appropriate balance of research 
and clinical responsibilities, including guarantee of 75 percent protected 
time for research for each WRHR Scholar.

ADDITIONAL REVIEW CRITERIA: In addition to the above criteria, the following 
items will be considered in the determination of scientific merit and the 
priority score:

PROTECTION OF HUMAN SUBJECTS FROM RESEARCH RISK:  The involvement of human 
subjects and protections from research risk relating to their participation 
in the proposed research will be assessed. (See criteria included in the 
section on Federal Citations, below.)
 
INCLUSION OF WOMEN, MINORITIES AND CHILDREN IN RESEARCH:  The adequacy of 
plans to include subjects from both genders, all racial and ethnic groups 
(and subgroups), and children as appropriate for the scientific goals of the 
research.  Plans for the recruitment and retention of subjects will also be 
evaluated.  (See Inclusion Criteria in the sections on Federal Citations, 
below.)

CARE AND USE OF VERTEBRATE ANIMALS IN RESEARCH:  If vertebrate animals are to 
be used in the project, the five items described under Section f of the PHS 
398 research grant application instructions (rev. 5/2001) will be assessed.  

ADDITIONAL CONSIDERATIONS 

DATA SHARING:  The adequacy of the proposed plan to share data.
 
BUDGET:  The reasonableness of the proposed budget and the requested period 
of support in relation to the proposed research.

RECEIPT AND REVIEW SCHEDULE

Letter of Intent Receipt Date:  June 30, 2003
Application Receipt Date:  July 29, 2003
Peer Review Date:  October/November 2003
Council Review:  January 2004
Earliest Anticipated Start Date:  April 01, 2004

AWARD CRITERIA

Criteria that will be used to make award decisions include: 

o Scientific merit (as determined by peer review)
o Availability of funds
o Programmatic priorities

REQUIRED FEDERAL CITATIONS

HUMAN SUBJECTS PROTECTION:  Federal regulations (45CFR46) require that 
applications and proposals involving human subjects must be evaluated with 
reference to the risks to the subjects, the adequacy of protection against 
these risks, the potential benefits of the research to the subjects and 
others, and the importance of the knowledge gained or to be gained.

MONITORING PLAN AND DATA SAFETY AND MONITORING BOARD:  Research components 
involving Phase I and II clinical trials must include provisions for 
assessment of patient eligibility and status, rigorous data management, 
quality assurance, and auditing procedures.  In addition, it is NIH policy 
that all clinical trials require data and safety monitoring, with the method 
and degree of monitoring being commensurate with the risks (NIH Policy for 
Data Safety and Monitoring, NIH Guide for Grants and Contracts, June 12, 
1998: http://grants.nih.gov/grants/guide/notice-files/not98-084.html).

INCLUSION OF WOMEN AND MINORITIES IN CLINICAL RESEARCH:  It is the policy of 
the NIH that women and members of minority groups and their sub-populations 
must be included in all NIH-supported clinical research projects unless a 
clear and compelling justification is provided indicating that inclusion is 
inappropriate with respect to the health of the subjects or the purpose of 
the research.  This policy results from the NIH Revitalization Act of 1993 
(Section 492B of Public Law 103-43).

All investigators proposing clinical research should read the "NIH Guidelines 
for Inclusion of Women and Minorities as Subjects in Clinical Research - 
Amended, October, 2001," published in the NIH Guide for Grants and Contracts 
on October 9, 2001 (http://grants.nih.gov/grants/guide/notice-files/
NOT-OD-02-001.html); a complete copy of the updated Guidelines is available 
at http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_
2001.htm.  The amended policy incorporates:  the use of an NIH definition 
of clinical research; updated racial and ethnic categories in compliance with 
the new OMB standards; clarification of language governing NIH-defined Phase 
III clinical trials consistent with the new PHS Form 398; and updated roles and 
responsibilities of NIH staff and the extramural community.  The policy 
continues to require for all NIH-defined Phase III clinical trials that: a) 
all applications or proposals and/or protocols must provide a description of 
plans to conduct analyses, as appropriate, to address differences by 
sex/gender and/or racial/ethnic groups, including subgroups if applicable; 
and b) investigators must report annual accrual and progress in conducting 
analyses, as appropriate, by sex/gender and/or racial/ethnic group 
differences.

INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS: 
The NIH maintains a policy that children (i.e., individuals under the age of 
21) must be included in all human subjects research, conducted or supported 
by the NIH, unless there are scientific and ethical reasons not to include 
them.  This policy applies to all initial (Type 1) applications submitted for 
receipt dates after October 1, 1998.

All investigators proposing research involving human subjects should read the 
"NIH Policy and Guidelines" on the inclusion of children as participants in 
research involving human subjects that is available at 
http://grants.nih.gov/grants/funding/children/children.htm.

REQUIRED EDUCATION ON THE PROTECTION OF HUMAN SUBJECT PARTICIPANTS:  NIH 
policy requires education on the protection of human subject participants for 
all investigators submitting NIH proposals for research involving human 
subjects.  You will find this policy announcement in the NIH Guide for Grants 
and Contracts Announcement, dated June 5, 2000, at 
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.

HUMAN EMBRYONIC STEM CELLS (hESC):  Criteria for federal funding of research 
on hESCs can be found at http://grants.nih.gov/grants/stem_cells.htm and at 
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html.  Only 
research using hESC lines that are registered in the NIH Human Embryonic Stem 
Cell Registry will be eligible for Federal funding (see http://escr.nih.gov).   
It is the responsibility of the applicant to provide the official NIH 
identifier(s)for the hESC line(s)to be used in the proposed research.  
Applications that do not provide this information will be returned without 
review. 

PUBLIC ACCESS TO RESEARCH DATA THROUGH THE FREEDOM OF INFORMATION ACT:  The 
Office of Management and Budget (OMB) Circular A-110 has been revised to 
provide public access to research data through the Freedom of Information Act 
(FOIA) under some circumstances.  Data that are (1) first produced in a 
project that is supported in whole or in part with Federal funds and (2) 
cited publicly and officially by a Federal agency in support of an action 
that has the force and effect of law (i.e., a regulation) may be accessed 
through FOIA.  It is important for applicants to understand the basic scope 
of this amendment.  NIH has provided guidance at 
http://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm.

Applicants may wish to place data collected under this RFA in a public 
archive, which can provide protections for the data and manage the 
distribution for an indefinite period of time.  If so, the application should 
include a description of the archiving plan in the study design and include 
information about this in the budget justification section of the 
application.  In addition, applicants should think about how to structure 
informed consent statements and other human subjects procedures given the 
potential for wider use of data collected under this award.

STANDARDS FOR PRIVACY OF INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION:  The 
Department of Health and Human Services (DHHS) issued final modification to 
the "Standards for Privacy of Individually Identifiable Health Information", 
the "Privacy Rule," on August 14, 2002.  The Privacy Rule is a federal 
regulation under the Health Insurance Portability and Accountability Act 
(HIPAA) of 1996 that governs the protection of individually identifiable 
health information, and is administered and enforced by the DHHS Office for 
Civil Rights (OCR). Those who must comply with the Privacy Rule (classified 
under the Rule as "covered entities") must do so by April 14, 2003  (with the 
exception of small health plans which have an extra year to comply).  

Decisions about applicability and implementation of the Privacy Rule reside 
with the researcher and his/her institution. The OCR website 
(http://www.hhs.gov/ocr/) provides information on the Privacy Rule, including 
a complete Regulation Text and a set of decision tools on "Am I a covered 
entity?"  Information on the impact of the HIPAA Privacy Rule on NIH 
processes involving the review, funding, and progress monitoring of grants, 
cooperative agreements, and research contracts can be found at 
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.

URLs IN NIH GRANT APPLICATIONS OR APPENDICES:  All applications and proposals 
for NIH funding must be self-contained within specified page limitations. 
Unless otherwise specified in an NIH solicitation, Internet addresses (URLs) 
should not be used to provide information necessary to the review because 
reviewers are under no obligation to view the Internet sites.  Furthermore, 
we caution reviewers that their anonymity may be compromised when they 
directly access an Internet site.

HEALTHY PEOPLE 2010:  The Public Health Service (PHS) is committed to 
achieving the health promotion and disease prevention objectives of "Healthy 
People 2010," a PHS-led national activity for setting priority areas.  This 
RFA is related to one or more of the priority areas.  Potential applicants 
may obtain a copy of "Healthy People 2010" at 
http://www.health.gov/healthypeople. 

AUTHORITY AND REGULATIONS:  This program is described in the Catalog of 
Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the 
intergovernmental review requirements of Executive Order 12372 or Health 
Systems Agency review.  Awards are made under the authorization of Sections 
301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284)  
and under Federal Regulations 42 CFR 52 and 45 CFR Parts 74 and 92.  All 
awards are subject to the terms and conditions, cost principles, and other 
considerations described in the NIH Grants Policy Statement.  The NIH Grants 
Policy Statement can be found at 
http://grants.nih.gov/grants/policy/policy.htm. 

The PHS strongly encourages all grant recipients to provide a smoke-free 
workplace and discourage the use of all tobacco products.  In addition, 
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in 
certain facilities (or in some cases, any portion of a facility) in which 
regular or routine education, library, day care, health care, or early 
childhood development services are provided to children.  This is consistent 
with the PHS mission to protect and advance the physical and mental health of 
the American people.


Return to Volume Index

Return to NIH Guide Main Index


H H S Department of Health
and Human Services

 
  N I H National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892